Polymer-enhanced surfactant

Drug Profile

Polymer-enhanced surfactant

Alternative Names: Inactivation-resistant surfactant; Surfactant - Karolinska Institute/UCSF/University of Rochester

Latest Information Update: 29 Apr 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Surfactants
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Meconium aspiration syndrome; Neonatal respiratory distress syndrome

Most Recent Events

  • 14 Jun 1999 Preclinical development for Meconium aspiration syndrome in USA (Intratracheal)
  • 14 Jun 1999 Preclinical development for Neonatal respiratory distress syndrome in USA (Intratracheal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top